// App-Quantinova.ai

: Improvements in Lymphoma Symptoms and Health-Related Quality of Life in Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Subcutaneous Epcoritamab (EPCORE NHL-1)

Researchers

Presenter

  • Tycel Phillips

Principal Investigators

  • Pieternella Lugtenburg

  • Anupama Kalsekar

  • Alex Mutebi

  • Anthony Wang

  • Julie Blaedel

  • Katherine Kosa

  • Susan Martin

  • Mariana Sacchi

  • Catherine Thieblemont

Medical Centers

  • Department of Hematology, On behalf of the HOVON lymphoma working group, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands

  • APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France; Diderot University, Sorbonne Paris-Cité, Paris, France

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Locations

  • United States

  • Netherlands

  • France

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Cohort

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved